Related Experiment Video
Updated: May 28, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Left Ventricular Assist Device Emergencies: Diagnosis and Management
Susie Sennhauser1, Lakshmi Sridharan1
1Division of Cardiology, Department of Medicine, Emory University School of Medicine.
Insights
Durable left ventricular assist devices (LVADs) offer advanced therapy for end-stage heart failure. Managing LVAD emergencies is crucial due to the growing patient population and increasing heart failure diagnoses.
Area of Science:
- Cardiology
- Medical Devices
- Heart Failure Management
Background:
- End-stage heart failure affects a significant patient population, with 30-40% classified as NYHA class III or IV in 2019.
- Heart failure accounted for over 3.2 million office visits and 1.4 million emergency department visits in 2018.
- The increasing prevalence of heart failure necessitates advanced therapeutic options.
Purpose of the Study:
- To highlight the importance of managing perioperative and outpatient emergencies in patients with left ventricular assist devices (LVADs).
- To underscore the growing need for clinical expertise in LVAD-related complications.
- To address the challenges posed by the expanding LVAD population.
Main Methods:
- Review of current literature on left ventricular assist device (LVAD) therapy.
- Analysis of epidemiological data for heart failure prevalence and LVAD utilization.
- Discussion of common perioperative and outpatient emergencies associated with LVADs.
Main Results:
- Left ventricular assist devices (LVADs) represent a vital therapeutic option for advanced heart failure.
- The number of patients requiring LVADs is rapidly increasing.
- Expertise in diagnosing and managing LVAD emergencies is becoming essential.
Conclusions:
- The growing LVAD population requires enhanced clinical preparedness for managing device-related emergencies.
- Effective management of LVAD complications is critical for patient outcomes.
- Healthcare providers must be proficient in the diagnosis and treatment of LVAD emergencies across various clinical settings.
Abstract:
Durable left ventricular assist devices (LVADs) are a virtually limitless advanced therapy option for an increasingly growing population of patients with end-stage advanced heart failure. As of 2019, 30% to 40% of all patients diagnosed with heart failure were categorized as New York Heart Association class III or IV. In 2018 more than 3.2 million office visits and 1.4 million emergency department visits carried a primary diagnosis of heart failure. Given the rapid growth of the LVAD population, facility in the diagnosis and management of common perioperative and outpatient LVAD emergencies has become of paramount importance in a variety of clinical settings.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Heart Failure V: Medical Management
Introduction Cardiac Emergencies
Dysrhythmias V: Evaluating Dysrhythmias
Heart Failure VI: Adjunct Therapies
